A new analysis finds medicines often are not accessible countries where they were tested before approval by the FDA, raising ...

WASHINGTON — Sen. Bill Cassidy (R-La.) is pitching Democrats on his compromise to make Affordable Care Act marketplace plans ...

The FDA has cleared home use of a device that helps people with spinal cord injuries regain mobility and functioning.

Over 74,000 people enrolled in experiments have been affected by the NIH's funding cuts, according to a new report.

Johnson & Johnson said it will purchase Halda Therapeutics, marking the first major buyout for a cancer drugmaker built ...

Johnson & Johnson said it is acquiring Halda Therapeutics, a developer of cancer drugs, for $3.05 billion. Halda’s lead ...

The toll from cervical cancer is highest in lower-income countries, which often lack screening programs that can result in ...

Novo Nordisk has begun selling Wegovy for $349 a month to cash payers, months ahead of the timeline set out with the Trump ...

Nuvalent said its drug for ALK+ lung cancer shrank tumors in more than a quarter of patients whose disease had returned after ...

We both lost our jobs as public health diplomats with the U.S. Agency for International Development last summer. Our termination from federal service also meant that both of us lo ...

WuXi AppTec, the Chinese pharma giant with extensive ties with U.S. companies, appears to be thriving now that the threat of ...

ROAI isn't about flashy demos or model size. It's about measurable improvements,” writes Sanofi CEO Paul Hudson.